Short Interest in MariMed Inc. (OTCMKTS:MRMD) Declines By 84.0%

MariMed Inc. (OTCMKTS:MRMD) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,327 shares, a drop of 84.0% from the April 30th total of 20,807 shares. Based on an average trading volume of 1,290,557 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

MariMed Trading Down 3.9%

Shares of MariMed stock traded down $0.00 on Thursday, reaching $0.07. The company had a trading volume of 407,680 shares, compared to its average volume of 579,422. The firm’s 50 day moving average price is $0.08 and its two-hundred day moving average price is $0.08. The company has a debt-to-equity ratio of 1.67, a quick ratio of 0.34 and a current ratio of 0.95. MariMed has a 52-week low of $0.06 and a 52-week high of $0.23. The firm has a market cap of $28.78 million, a PE ratio of -2.40 and a beta of 1.33.

MariMed (OTCMKTS:MRMD) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). MariMed had a negative net margin of 7.82% and a negative return on equity of 5.00%. The firm had revenue of $39.48 million during the quarter, compared to analysts’ expectations of $38.75 million. Sell-side analysts predict that MariMed will post -0.04 earnings per share for the current fiscal year.

MariMed Company Profile

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.